Cargando…
Two Decades of Cardiovascular Trials With Primary Surrogate Endpoints: 1990–2011
BACKGROUND: Surrogate endpoint trials test strategies more efficiently but are accompanied by uncertainty about the relationship between changes in surrogate markers and clinical outcomes. METHODS AND RESULTS: We identified cardiovascular trials with primary surrogate endpoints published in the New...
Autores principales: | Bikdeli, Behnood, Punnanithinont, Natdanai, Akram, Yasir, Lee, Ike, Desai, Nihar R., Ross, Joseph S., Krumholz, Harlan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524035/ https://www.ncbi.nlm.nih.gov/pubmed/28325713 http://dx.doi.org/10.1161/JAHA.116.005285 |
Ejemplares similares
-
Age of Data at the Time of Publication of Contemporary Clinical Trials
por: Welsh, John, et al.
Publicado: (2018) -
Surrogate endpoints.
por: Ellenberg, S. S.
Publicado: (1993) -
Availability of Clinical Trial Data From Industry‐Sponsored Cardiovascular Trials
por: Murugiah, Karthik, et al.
Publicado: (2016) -
The evaluation of surrogate endpoints
por: Burzykowski, Tomasz, et al.
Publicado: (2005) -
Surrogate Endpoints in Medicine
por: Srivastava, Sudhir, et al.
Publicado: (2002)